WASHINGTON (MedPage Today) -- Transcatheter aortic valve replacement with CoreValve had durable survival benefits at 2 years for extreme-risk aortic stenosis patients and was cost-effective for high-risk patients too, studies showed. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment